Prevalence and Predictors of Persistent Human Immunodeficiency Virus Viremia and Viral Rebound After Universal Test and Treat: A Population-Based Study
dc.contributor.author | Grabowski, M. Kate | |
dc.contributor.author | Patel, Eshan U. | |
dc.contributor.author | Nakigozi, Gertrude | |
dc.contributor.author | Ssempijja, Victor | |
dc.contributor.author | Ssekubugu, Robert | |
dc.contributor.author | Ssekasanvu, Joseph | |
dc.contributor.author | Ndyanabo, Anthony | |
dc.contributor.author | Kigozi, Godfrey | |
dc.contributor.author | Nalugoda, Fred | |
dc.contributor.author | Gray, Ronald H. | |
dc.contributor.author | Kalibbala, Sarah | |
dc.contributor.author | Serwadda, David M. | |
dc.contributor.author | Laeyendecker, Oliver | |
dc.contributor.author | Wawer, Maria J. | |
dc.contributor.author | Chang, Larry W. | |
dc.contributor.author | Quinn, Thomas C. | |
dc.contributor.author | Kagaayi, Joseph | |
dc.contributor.author | Tobian, Aaron A. R. | |
dc.contributor.author | Reynolds, Steven J. | |
dc.date.accessioned | 2022-01-20T21:49:56Z | |
dc.date.available | 2022-01-20T21:49:56Z | |
dc.date.issued | 2021 | |
dc.description.abstract | UNAIDS targets for human immunodeficiency virus (HIV) epidemic control by 2030 include that 86% of all HIV-positive persons be on antiretroviral therapy (ART) and achieve HIV viral load (VL) suppression [1]. The major policy initiative underpinning this target is universal test and treat (UTT), whereby all HIV-positive persons, irrespective of CD4 count or severity of illness, are immediately prescribed ART [2]. In sub-Saharan Africa, which accounts for more than half of all new HIV diagnoses globally, there has been considerable progress in increasing ART coverage [ | en_US |
dc.identifier.citation | Grabowski, M. K., Patel, E. U., Nakigozi, G., Ssempijja, V., Ssekubugu, R., Ssekasanvu, J., ... & Reynolds, S. J. (2021). Prevalence and Predictors of Persistent Human Immunodeficiency Virus Viremia and Viral Rebound After Universal Test and Treat: A Population-Based Study. The Journal of infectious diseases, 223(7), 1150-1160. DOI: 10.1093/infdis/jiab021 | en_US |
dc.identifier.other | 10.1093/infdis/jiab021 | |
dc.identifier.uri | https://nru.uncst.go.ug/xmlui/handle/123456789/1367 | |
dc.language.iso | en | en_US |
dc.publisher | The Journal of infectious diseases | en_US |
dc.subject | Africa | en_US |
dc.subject | Cohort studies | en_US |
dc.subject | HIV prevention | en_US |
dc.subject | Universal test and treat | en_US |
dc.subject | Viral suppression | en_US |
dc.title | Prevalence and Predictors of Persistent Human Immunodeficiency Virus Viremia and Viral Rebound After Universal Test and Treat: A Population-Based Study | en_US |
dc.type | Article | en_US |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Prevalence and Predictors of Persistent Human.pdf
- Size:
- 384.07 KB
- Format:
- Adobe Portable Document Format
- Description:
- Article
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 1.71 KB
- Format:
- Item-specific license agreed upon to submission
- Description: